Alex Sapir is CEO & President at Dova Pharmaceuticals, Inc. (DOVA). They have made 3 open-market trades across 2 companies since 2017, most recently 2024-07-03.
CIK 0001709415
3 open-market purchases totalling $1.8M since 2017, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.